Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Mother-daughter businesses connected by sustainability, faith, yearning for community
Quoleshna Elbert wants to get — and give — the most bang for her buck, she said. “I’m the person who wants to kill three birds with one stone,” explained the founder of Community Local, an eco-friendly T-shirt brand based in Kansas City. Such drive is hereditary. “We want to be able to go deeper…
17-year-old entrepreneurs find financial, moral support for My Social Gain
Entrepreneurship brought Jaden Evans and Benicio Baeza together, they said. The two juniors at Truman High School in Independence, Missouri, started the social media marketing company My Social Gain in early 2018 after realizing the power of social media for companies. Though the company is only a few months old, My Social Gain already has…
‘We’re a big damn deal!’ KC is an underground fintech hub, says Zach Pettet
Editor’s note: Zach Pettet is the Fintech Strategist at nbkc bank, with which Startland News has partnered on an upcoming Innovation Exchange event. Opinions expressed in this commentary are the author’s alone. Kansas City is the United States’ underground financial center. Over the years, many financial juggernauts have been born and grown up in Kansas…
Traditional marketing tactics fail to wow consumers, Boomn startup says
If an idea doesn’t prompt a “Heck yeah!” response from the team at Boomn, it gets an “Um, no” verdict, said Ryan O’Connell. A data-driven and performance-based digital marketing company, KC-based Boomn works primarily with ecommerce brands. Such clients range from food and beverage companies to TV and YouTube personalities, said O’Connell, Boomn’s chief operating…